mci 9038 and ozagrel
mci 9038 has been researched along with ozagrel in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bai, T; Feng, Q; Guo, T; Jia, J; Li, X; Liu, Y; Pei, J; Song, Y; Wu, L; Wu, S; Zhang, Y; Zheng, X | 1 |
| Kawai, H; Tamao, Y | 1 |
| Katayama, Y; Otsubo, K | 1 |
| Hosomi, N; Kohno, M; Mizushige, K; Ohyama, H; Takahashi, T | 1 |
| Aoki, T; Matsuoka, N; Mihara, K; Moriguchi, A; Mutoh, S; Tojo, N | 1 |
| Shinohara, Y | 1 |
| Adachi, H; Ishibashi, A; Yoshitake, Y | 1 |
| Abe, S; Mitaki, S; Oguro, H; Onoda, K; Takayoshi, H; Yamaguchi, S | 1 |
Reviews
3 review(s) available for mci 9038 and ozagrel
| Article | Year |
|---|---|
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
Topics: Fibrinolytic Agents; Humans; Molecular Structure; Thrombosis | 2022 |
[Therapeutic time window in ischemic stroke].
Topics: Animals; Arginine; Drug Therapy, Combination; Heparin; Humans; Methacrylates; Pipecolic Acids; Recombinant Proteins; Streptokinase; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator | 2000 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
Other Studies
5 other study(ies) available for mci 9038 and ozagrel
| Article | Year |
|---|---|
The combination of thrombin inhibitor and thromboxane synthase inhibitor on experimental thrombosis and bleeding.
Topics: Animals; Antithrombins; Arginine; Bleeding Time; Drug Synergism; Drug Therapy, Combination; Infusions, Intravenous; Male; Methacrylates; Pipecolic Acids; Rabbits; Sulfonamides; Thrombin; Thrombosis; Thromboxane-A Synthase | 1995 |
Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia.
Topics: Animals; Antithrombins; Arginine; Aspirin; Blood Pressure; Brain Edema; Cerebrovascular Circulation; Fibrinolytic Agents; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Methacrylates; Microcirculation; Nerve Degeneration; Neurons; Pipecolic Acids; Sulfonamides; Survival Rate; Thrombin | 2001 |
Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
Topics: Animals; Antithrombins; Arginine; Blood Coagulation; Blood Platelets; Brain Ischemia; Disease Models, Animal; Guinea Pigs; Infarction, Middle Cerebral Artery; Male; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Sulfonamides; Thromboxane B2 | 2004 |
Investigation of effect of edaravone on ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Antipyrine; Arginine; Edaravone; Female; Free Radical Scavengers; Humans; Ischemia; Male; Methacrylates; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Factors; Stroke; Sulfonamides; Young Adult | 2013 |
Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Methacrylates; Middle Aged; Pipecolic Acids; Prognosis; Retrospective Studies; Severity of Illness Index; Stroke; Sulfonamides | 2018 |